The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment

Monica Parry; Harriette G.C. Van Spall; Kerri Anne Mullen; Sharon L. Mulvagh; Christine Pacheco; Tracey J.F. Colella; Marie Annick Clavel; Shahin Jaffer; Heather J.A. Foulds; Jasmine Grewal; Marsha Hardy; Jennifer A.D. Price; Anna L.E. Levinsson; Christine A. Gonsalves; Colleen M. Norris

doi:10.1016/j.cjco.2022.04.002

The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment

Monica Parry, Harriette G.C. Van Spall, Kerri Anne Mullen, Sharon L. Mulvagh, Christine Pacheco, Tracey J.F. Colella, Marie Annick Clavel, Shahin Jaffer, Heather J.A. Foulds, Jasmine Grewal, Marsha Hardy, Jennifer A.D. Price, Anna L.E. Levinsson, Christine A. Gonsalves, Colleen M. Norris

Medicine

Résultat de recherche: Review article › examen par les pairs

14 Citations (Scopus)

Résumé

This chapter summarizes the sex- and gender-specific diagnosis and treatment of acute/unstable presentations and nacute/stable presentations of cardiovascular disease in women. Guidelines, scientific statements, systematic reviews/meta-analyses, and primary research studies related to diagnosis and treatment of coronary artery disease, cerebrovascular disease (stroke), valvular heart disease, and heart failure in women were reviewed. The evidence is summarized as a narrative, and when available, sex- and gender-specific practice and research recommendations are provided. Acute coronary syndrome presentations and emergency department delays are different in women than they are in men. Coronary angiography remains the gold-standard test for diagnosis of obstructive coronary artery disease. Other diagnostic imaging modalities for ischemic heart disease detection (eg, positron emission tomography, echocardiography, single-photon emission computed tomography, cardiovascular magnetic resonance, coronary computed tomography angiography) have been shown to be useful in women, with their selection dependent upon both the goal of the individualized assessment and the testing resources available. Noncontrast computed tomography and computed tomography angiography are used to diagnose stroke in women. Although sex-specific differences appear to exist in the efficacy of standard treatments for diverse presentations of acute coronary syndrome, many cardiovascular drugs and interventions tested in clinical trials were not powered to detect sex-specific differences, and knowledge gaps remain. Similarly, although knowledge is evolving about sex-specific difference in the management of valvular heart disease, and heart failure with both reduced and preserved ejection fraction, current guidelines are lacking in sex-specific recommendations, and more research is needed.

Langue d'origine	English
Pages (de-à)	589-608
Nombre de pages	20
Journal	CJC Open
Volume	4
Numéro de publication	7
DOI	https://doi.org/10.1016/j.cjco.2022.04.002
Statut de publication	Published - juill. 2022

Note bibliographique

Funding Information:
This work was supported by the University of Ottawa Heart Institute Foundation .

Publisher Copyright:
© 2022 The Authors

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine

PubMed: MeSH publication types

Journal Article
Review

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/j.cjco.2022.04.002

Autres fichiers et liens

Empreinte numérique

Plonger dans les sujets de recherche 'The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment'. Ensemble, ils forment une empreinte numérique unique.

Citer

Parry, M., Van Spall, H. G. C., Mullen, K. A., Mulvagh, S. L., Pacheco, C., Colella, T. J. F., Clavel, M. A., Jaffer, S., Foulds, H. J. A., Grewal, J., Hardy, M., Price, J. A. D., Levinsson, A. L. E., Gonsalves, C. A., & Norris, C. M. (2022). The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment. CJC Open, 4(7), 589-608. https://doi.org/10.1016/j.cjco.2022.04.002

The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment. / Parry, Monica; Van Spall, Harriette G.C.; Mullen, Kerri Anne et al.
Dans: CJC Open, Vol. 4, N° 7, 07.2022, p. 589-608.

Résultat de recherche: Review article › examen par les pairs

Parry, M, Van Spall, HGC, Mullen, KA, Mulvagh, SL, Pacheco, C, Colella, TJF, Clavel, MA, Jaffer, S, Foulds, HJA, Grewal, J, Hardy, M, Price, JAD, Levinsson, ALE, Gonsalves, CA & Norris, CM 2022, 'The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment', CJC Open, vol. 4, n° 7, pp. 589-608. https://doi.org/10.1016/j.cjco.2022.04.002

@article{32f9f2186f634c768a07ee0cb40d9bae,

title = "The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment",

abstract = "This chapter summarizes the sex- and gender-specific diagnosis and treatment of acute/unstable presentations and nacute/stable presentations of cardiovascular disease in women. Guidelines, scientific statements, systematic reviews/meta-analyses, and primary research studies related to diagnosis and treatment of coronary artery disease, cerebrovascular disease (stroke), valvular heart disease, and heart failure in women were reviewed. The evidence is summarized as a narrative, and when available, sex- and gender-specific practice and research recommendations are provided. Acute coronary syndrome presentations and emergency department delays are different in women than they are in men. Coronary angiography remains the gold-standard test for diagnosis of obstructive coronary artery disease. Other diagnostic imaging modalities for ischemic heart disease detection (eg, positron emission tomography, echocardiography, single-photon emission computed tomography, cardiovascular magnetic resonance, coronary computed tomography angiography) have been shown to be useful in women, with their selection dependent upon both the goal of the individualized assessment and the testing resources available. Noncontrast computed tomography and computed tomography angiography are used to diagnose stroke in women. Although sex-specific differences appear to exist in the efficacy of standard treatments for diverse presentations of acute coronary syndrome, many cardiovascular drugs and interventions tested in clinical trials were not powered to detect sex-specific differences, and knowledge gaps remain. Similarly, although knowledge is evolving about sex-specific difference in the management of valvular heart disease, and heart failure with both reduced and preserved ejection fraction, current guidelines are lacking in sex-specific recommendations, and more research is needed.",

author = "Monica Parry and {Van Spall}, {Harriette G.C.} and Mullen, {Kerri Anne} and Mulvagh, {Sharon L.} and Christine Pacheco and Colella, {Tracey J.F.} and Clavel, {Marie Annick} and Shahin Jaffer and Foulds, {Heather J.A.} and Jasmine Grewal and Marsha Hardy and Price, {Jennifer A.D.} and Levinsson, {Anna L.E.} and Gonsalves, {Christine A.} and Norris, {Colleen M.}",

note = "Funding Information: This work was supported by the University of Ottawa Heart Institute Foundation . Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2022",

month = jul,

doi = "10.1016/j.cjco.2022.04.002",

language = "English",

volume = "4",

pages = "589--608",

journal = "CJC Open",

issn = "2589-790X",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6

T2 - Sex- and Gender-Specific Diagnosis and Treatment

AU - Parry, Monica

AU - Van Spall, Harriette G.C.

AU - Mullen, Kerri Anne

AU - Mulvagh, Sharon L.

AU - Pacheco, Christine

AU - Colella, Tracey J.F.

AU - Clavel, Marie Annick

AU - Jaffer, Shahin

AU - Foulds, Heather J.A.

AU - Grewal, Jasmine

AU - Hardy, Marsha

AU - Price, Jennifer A.D.

AU - Levinsson, Anna L.E.

AU - Gonsalves, Christine A.

AU - Norris, Colleen M.

PY - 2022/7

Y1 - 2022/7

N2 - This chapter summarizes the sex- and gender-specific diagnosis and treatment of acute/unstable presentations and nacute/stable presentations of cardiovascular disease in women. Guidelines, scientific statements, systematic reviews/meta-analyses, and primary research studies related to diagnosis and treatment of coronary artery disease, cerebrovascular disease (stroke), valvular heart disease, and heart failure in women were reviewed. The evidence is summarized as a narrative, and when available, sex- and gender-specific practice and research recommendations are provided. Acute coronary syndrome presentations and emergency department delays are different in women than they are in men. Coronary angiography remains the gold-standard test for diagnosis of obstructive coronary artery disease. Other diagnostic imaging modalities for ischemic heart disease detection (eg, positron emission tomography, echocardiography, single-photon emission computed tomography, cardiovascular magnetic resonance, coronary computed tomography angiography) have been shown to be useful in women, with their selection dependent upon both the goal of the individualized assessment and the testing resources available. Noncontrast computed tomography and computed tomography angiography are used to diagnose stroke in women. Although sex-specific differences appear to exist in the efficacy of standard treatments for diverse presentations of acute coronary syndrome, many cardiovascular drugs and interventions tested in clinical trials were not powered to detect sex-specific differences, and knowledge gaps remain. Similarly, although knowledge is evolving about sex-specific difference in the management of valvular heart disease, and heart failure with both reduced and preserved ejection fraction, current guidelines are lacking in sex-specific recommendations, and more research is needed.

AB - This chapter summarizes the sex- and gender-specific diagnosis and treatment of acute/unstable presentations and nacute/stable presentations of cardiovascular disease in women. Guidelines, scientific statements, systematic reviews/meta-analyses, and primary research studies related to diagnosis and treatment of coronary artery disease, cerebrovascular disease (stroke), valvular heart disease, and heart failure in women were reviewed. The evidence is summarized as a narrative, and when available, sex- and gender-specific practice and research recommendations are provided. Acute coronary syndrome presentations and emergency department delays are different in women than they are in men. Coronary angiography remains the gold-standard test for diagnosis of obstructive coronary artery disease. Other diagnostic imaging modalities for ischemic heart disease detection (eg, positron emission tomography, echocardiography, single-photon emission computed tomography, cardiovascular magnetic resonance, coronary computed tomography angiography) have been shown to be useful in women, with their selection dependent upon both the goal of the individualized assessment and the testing resources available. Noncontrast computed tomography and computed tomography angiography are used to diagnose stroke in women. Although sex-specific differences appear to exist in the efficacy of standard treatments for diverse presentations of acute coronary syndrome, many cardiovascular drugs and interventions tested in clinical trials were not powered to detect sex-specific differences, and knowledge gaps remain. Similarly, although knowledge is evolving about sex-specific difference in the management of valvular heart disease, and heart failure with both reduced and preserved ejection fraction, current guidelines are lacking in sex-specific recommendations, and more research is needed.

UR - http://www.scopus.com/inward/record.url?scp=85134342644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134342644&partnerID=8YFLogxK

U2 - 10.1016/j.cjco.2022.04.002

DO - 10.1016/j.cjco.2022.04.002

M3 - Review article

C2 - 35865023

AN - SCOPUS:85134342644

SN - 2589-790X

VL - 4

SP - 589

EP - 608

JO - CJC Open

JF - CJC Open

IS - 7

ER -